And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Not surprisingly, our agenda is exceedingly modest. We hope to putter around the campus grounds, get some fresh air by promenading with the energetic official mascot, and peer into the telly. And what about you? This is a good time to stretch your own legs. You could also touch base with older folks who feel isolated or simply catch up on your reading. Well, whatever you do, keep your chin up and your mask on. Enjoy, and see you soon. …

French President Emmanuel Macron will meet with Sanofi (SNY) executives on May 19, after Sanofi chief executive Hudson caused outrage by saying the U.S. would have priority access to any Covid-19 vaccine the company develops, Bloomberg News writes. Hudson later walked back his comments by saying it was vital any vaccine reach all parts of the world.  The U.S., which expanded a vaccine partnership with the company in February, expects “that if we’ve helped you manufacture the doses at risk, we expect to get the doses first,” Hudson said.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy